W. Hiddemann

1.8k total citations · 1 hit paper
2 papers, 969 citations indexed

About

W. Hiddemann is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, W. Hiddemann has authored 2 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 1 paper in Genetics and 1 paper in Oncology. Recurrent topics in W. Hiddemann's work include Lymphoma Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (1 paper) and Viral-associated cancers and disorders (1 paper). W. Hiddemann is often cited by papers focused on Lymphoma Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (1 paper) and Viral-associated cancers and disorders (1 paper). W. Hiddemann collaborates with scholars based in Germany, Australia and Switzerland. W. Hiddemann's co-authors include Martin Dreyling and has published in prestigious journals such as Blood and HemaSphere.

In The Last Decade

W. Hiddemann

2 papers receiving 942 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

2005 965 citations W. Hiddemann Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Hiddemann Germany	2	871	627	432	156	140	2	969
Andrej Vranovský Slovakia	8	675 0.8×	450 0.7×	406 0.9×	113 0.7×	116 0.8×	16	781
Elisabeth Wassner-Fritsch Switzerland	12	1.1k 1.3×	743 1.2×	768 1.8×	251 1.6×	124 0.9×	20	1.3k
Charles Foussard France	12	885 1.0×	601 1.0×	356 0.8×	85 0.5×	195 1.4×	22	1.0k
J. Matthews United Kingdom	13	988 1.1×	664 1.1×	428 1.0×	73 0.5×	158 1.1×	20	1.1k
David Belada Czechia	18	819 0.9×	604 1.0×	327 0.8×	162 1.0×	175 1.3×	167	1.1k
Keith Dawson United States	11	841 1.0×	702 1.1×	288 0.7×	42 0.3×	131 0.9×	32	960
F. Morschhauser France	13	693 0.8×	449 0.7×	182 0.4×	137 0.9×	166 1.2×	27	944
C. Jonas United States	4	509 0.6×	350 0.6×	266 0.6×	161 1.0×	87 0.6×	9	718
C. G. A. Price United Kingdom	13	849 1.0×	589 0.9×	426 1.0×	66 0.4×	121 0.9×	15	1.1k
Michelle Byrtek United States	12	964 1.1×	847 1.4×	316 0.7×	41 0.3×	161 1.1×	29	1.1k

Countries citing papers authored by W. Hiddemann

Since Specialization

Citations

This map shows the geographic impact of W. Hiddemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Hiddemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Hiddemann more than expected).

Fields of papers citing papers by W. Hiddemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Hiddemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Hiddemann. The network helps show where W. Hiddemann may publish in the future.

Co-authorship network of co-authors of W. Hiddemann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Hiddemann. A scholar is included among the top collaborators of W. Hiddemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Hiddemann. W. Hiddemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Hiddemann, W., et al.. (2022). S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF THE GALLIUM STUDY. HemaSphere. 6. 107–108. 4 indexed citations

2.

Hiddemann, W.. (2005). Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 106(12). 3725–3732. 965 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact